Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1I.v. selexipag
(Uptravi (TN))		[1] Selexipag (UPTRAVI Titration Pack)[1] Selexipag (Uptravi (TN)) 💬 [1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
2Observational study with patients treated with Tracleer, Ventavis, Veletri, Opsumit and/or Uptravi[4] Epoprostenol,
Iloprost,
Macitentan,
Selexipag (UPTRAVI Titration Pack)		[4] Epoprostenol ,
Iloprost ,
Selexipag (Uptravi (TN)),
Macitentan 💬 		[3] EDNRA,
EDNRB,
PTGIR 💬 		[10] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Platelet activation, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
3Oral selexipag (Uptravi)[1] Selexipag (UPTRAVI Titration Pack)[1] Selexipag (Uptravi (TN)) 💬 [1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
4SELEXIPAG
(Uptravi (TN))		[1] Selexipag (UPTRAVI Titration Pack)[1] Selexipag (Uptravi (TN)) 💬 [1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[5] 51, 70, 84, 86, 88 💬
5Selexipag (Uptravi)[1] Selexipag (UPTRAVI Titration Pack)[1] Selexipag (Uptravi (TN)) 💬 [1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
6Selexipag, ACT-293987 (NS-304)
(Uptravi (TN))		[1] Selexipag (UPTRAVI Titration Pack)[1] Selexipag (Uptravi (TN)) 💬 [1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
7Uptravi[1] Selexipag (UPTRAVI Titration Pack)[1] Selexipag (Uptravi (TN)) 💬 [1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[3] 84, 86, 88 💬